Fig. 2From: Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrenceiv-SIL treatment elevates circulating pDC/mDC ratio. PBMC were analyzed before (pre) and after (post) iv-SIL treatment by flow cytometry, as described in the “Methods” section. The frequencies of pDC (a Lin−BDCA-2+) and mDC (b Lin−BDCA-1+), correlation between mDC and AST at the end of treatment (c), and the pDC/mDC ratio (d) are shownBack to article page